Literature DB >> 22478852

Lots of enthusiasm, lots of questions.

Michael D Dalzell.   

Abstract

Value-based benefit design is all the rage, but applying it to biologics is complicated. Several issues must be addressed if VBBD is to rule this frontier.

Year:  2011        PMID： 22478852      PMCID： PMC3138390     

Source DB:  PubMed          Journal:  Biotechnol Healthc        ISSN： 1554-169X


  4 in total

1.  Applying value-based insurance design to high-cost health services.

Authors:  James C Robinson
Journal:  Health Aff (Millwood)       Date:  2010-11       Impact factor: 6.301

2.  Reducing patient drug acquisition costs can lower diabetes health claims.

Authors:  John J Mahoney
Journal:  Am J Manag Care       Date:  2005-08       Impact factor: 2.229

3.  Evidence that value-based insurance can be effective.

Authors:  Michael E Chernew; Iver A Juster; Mayur Shah; Arnold Wegh; Stephen Rosenberg; Allison B Rosen; Michael C Sokol; Kristina Yu-Isenberg; A Mark Fendrick
Journal:  Health Aff (Millwood)       Date:  2010-01-21       Impact factor: 6.301

4.  The Asheville Project: factors associated with outcomes of a community pharmacy diabetes care program.

Authors:  Carole W Cranor; Dale B Christensen
Journal:  J Am Pharm Assoc (Wash)       Date:  2003 Mar-Apr
  4 in total
  2 in total

1.  Biologics and the Principles of Health Insurance: What is the purpose of health insurance? This review of basic insurance concepts provides a context for discussions about coverage of biologics.

Authors: 
Journal:  Biotechnol Healthc       Date:  2012

2.  Value-Based Benefit Design to Improve Medication Adherence for Employees with Anxiety or Depression.

Authors:  Kimberly J Reid; Kathleen M Aguilar; Eric Thompson; Ross M Miller
Journal:  Am Health Drug Benefits       Date:  2015 Jul-Aug
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.